Wells Fargo Downgrades Kymera Therapeutics (KYMR) to Equal Weight, 'Lack of Catalysts in 2024'

Go back to Wells Fargo Downgrades Kymera Therapeutics (KYMR) to Equal Weight, 'Lack of Catalysts in 2024'
(NASDAQ: KYMR) Delayed: 121.10 -0.31 (0.26%)
Previous Close $121.41    52 Week High
Open $119.75    52 Week Low
Day High $121.23    P/E N/A 
Day Low $118.09    EPS
Volume 274,794